New FY 2025 NIH Categorical Spending Data Available

NIH recently updated its annual categorical information with actual spending data for fiscal year (FY) 2025. 

Available on the Research, Condition, and Disease Categorization (RCDC) page, you will find the annual support level for various research, condition, and disease categories. The data are based on grants, contracts, intramural projects, and other funding mechanisms used across NIH.

Beginning in FY 2025, NIH updated its reporting methodology to improve consistency and reduce double counting across certain funding sources. As a result, some FY 2025 funding levels reflect methodological changes rather than actual decreases. For categories impacted by this change by 2% or more, the FY 2023 and FY 2024 funding levels shown in parentheses reflect amounts recalculated under the current methodology. 

There were 215 public categories when RCDC information began being reported for FY 2008. In FY 2025, there are now a total of 332 categories. 

The following new categories were added in FY 2025:

• Adult/Somatic Stem Cell and Progenitor Cell Research
• Cerebral Visual Impairment (CVI)
• Digital Health
• End Stage Renal Disease
• Geroscience
• Human Embryonic Stem Cell Research
• Induced Pluripotent Stem Cell Research
• Men's Health Research
• Penile Diseases
• Prostate Disease
• Sjogren's Disease
• Stem Cell and Progenitor Cell Research
• Testicular Cancer
• Translational Research
• Urinary Incontinence
• Urinary Infection

No existing categories were renamed.

Resource:

• RCDC Categories At A Glance

Questions? [email protected]